Key result
Cigarette smoking is associated with enhanced clinical efficacy of oral P2Y12 inhibitors in patients with high-risk coronary artery disease.
Key points are not available for this paper at this time.
Answers are grounded in this paper and cite their sources.
Should not yet change practice; leaves open whether smoking modifies P2Y12 inhibitor efficacy in high-risk CAD.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Baker et al. (2014) studied this question. Cigarette smoking is associated with enhanced clinical efficacy of oral P2Y12 inhibitors in patients with high-risk coronary artery disease.
Synapse has enriched 10 related papers. Consider them for comparative context: